Detalhe da pesquisa
1.
Investigation of biomarkers to predict outcomes in allogeneic hematopoietic stem cell transplantation.
Cytotherapy
; 2024 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38625069
2.
Prognostic significance of the CFA ratio for newly diagnosed acute myeloid leukemia: A multicenter retrospective study.
Hematol Oncol
; 42(1): e3228, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37731313
3.
A case of Bloom syndrome manifesting with therapy-related myelodysplastic syndromes harboring a novel BLM gene variant.
Int J Hematol
; 119(5): 603-607, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38489090
4.
Comparison of standardized prophylactic high-dose and intrathecal methotrexate for DLBCL with a high risk of CNS relapse.
Int J Hematol
; 119(2): 164-172, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38233702
5.
Computed tomography-defined sarcopenia: prognostic predictor of nonrelapse mortality after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study.
Int J Hematol
; 112(1): 46-56, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32451786
6.
Impact of treatment-related weight changes from diagnosis to hematopoietic stem-cell transplantation on clinical outcome of acute myeloid leukemia.
Int J Hematol
; 109(6): 673-683, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30963469